Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
Oncolytics Biotech Inc. - Common Shares (ONCY)
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.oncolyticsbiotech.com
Company Research
Source: PR Newswire
VANCOUVER, B.C., Feb. 24, 2021 /PRNewswire/ -- USA News Group - The way we think about treating brain cancers is being quietly revolutionized, buried beneath recent headline-grabbing announcements pertaining to COVID-19. A series of discoveries and breakthroughs in oncology, especially those targeting glioblastoma—the most common and aggressive form of brain cancer in adults. Over the span of just a month, researchers in Canada, the USA, and Israel have announced breakthrough discoveries that could upend the field for years to come. While projections for the Global Brain Tumor Therapeutics Market are expected to hit $3.4 billion by the end 2025, the pharma sector is answering the call with their own studies for proprietary treatments, including companies such as Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Northwest Biotherapeutics, Inc. (OTCQB: NWBO), Inovio Pharmaceuticals, Inc. (NASDAQ: INO), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), and Sanofi (NASDAQ: SNY).Positive
Show less
Read more
Impact Snapshot
Event Time:
ONCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCY alerts
High impacting Oncolytics Biotech Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ONCY
News
- Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]Yahoo! Finance
- Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational HighlightsPR Newswire
- Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036PR Newswire
- Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036PR Newswire
- Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to ClimbPR Newswire
ONCY
Earnings
- 5/9/24 - In-Line
ONCY
Sec Filings
- 5/9/24 - Form 6-K
- 5/9/24 - Form 6-K
- 5/9/24 - Form 6-K
- ONCY's page on the SEC website